A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand
2018 ◽
Vol 16
(3)
◽
pp. 331-345
◽
2017 ◽
Vol 15
(1)
◽
2008 ◽
Vol 10
(1)
◽
pp. 25-38
◽